再鼎医药有限公司（09688）于2026年11月12日公告，基于先前已披露的股权激励计划，分别向参与人及董事发行新股，合计约710万股股份。其中，向参与人发行约630.11万股，占当时已发行股本约0.5%；另向董事发行约79.89万股，占当时已发行股本约0.06%。发行股份每股价格为0港元。
本次股份发行完成后，公司已发行股本由2026年10月31日的12.51亿股增至12.58亿股。公司在公告中表示，相关发行已获董事会正式授权，并严格遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由公司秘书F. Ty Edmondson签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.